Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03340025 · ClinicalTrials.gov registry record · NA
Single-Use Negative Pressure Wound Therapy for Free Flap Donor Sites
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03340025 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants.
The verdict
NCT03340025, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Various management options for free flap donor sites that require split thickness skin grafting exist. None has proven superior from both a patient care and a cost standpoint. Major complications occurring at these surgical sites include wound breakdown, tendon exposure, and loss of function. We seek to investigate the use of the PICO single-use negative pressure wound therapy device in these surgical sites and determine if it can yield superior results to simpler methods.
Interventions
- DEVICE PICO Single Use Negative Pressure Wound Therapy System
- DEVICE xeroform gauze
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-06-15 |
| Est. Completion | 2021-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03340025
The ClinicalTrials.gov registry entry for NCT03340025 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PICO Single Use Negative Pressure Wound Therapy System is the first listed.
NCT03340025 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03340025 about?
NCT03340025 is a clinical study titled "Single-Use Negative Pressure Wound Therapy for Free Flap Donor Sites". Various management options for free flap donor sites that require split thickness skin grafting exist. None has proven superior from both a patient care and a cost standpoint. Major complications occurring at these surgical sites include wound breakdown, tendon exposure, and loss of function. We see...
What is the current status of trial NCT03340025?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-06-15. Estimated completion is 2021-06-15.
What interventions are being tested in trial NCT03340025?
The interventions under investigation include: PICO Single Use Negative Pressure Wound Therapy System (DEVICE), xeroform gauze (DEVICE).
Who is sponsoring clinical trial NCT03340025?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.